Last reviewed · How we verify

NCT04667559

A Study to Evaluate the Conformis iTotal Identity Knee Replacement System

Terminated Last updated 25 October 2023
What this trial tests

trial testing Conformis iTotal Identity Knee Replacement System in Osteoarthritis, Knee in 22 participants. Terminated before completion.

Timeline
12 October 2020
Primary endpoint
14 December 2022
14 December 2022

Quick facts

Lead sponsorRestor3D
StatusTerminated
Study typeOBSERVATIONAL
Enrollment22
Start date12 October 2020
Primary completion14 December 2022
Estimated completion14 December 2022
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Restor3D

Who can join

18 and older, any sex, with Osteoarthritis, Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective multicenter study located in the United States. Subjects will be implanted with an iTotal Identity Knee Replacement System and followed for 10 years post implantation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Osteoarthritis, Knee

Currently open trials in the same condition.

Other Restor3D trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04667559.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing